Ironwood pharmaceuticals ma
WebIronwood Pharmaceuticals is an entrepreneurial pharmaceutical company, engages in developing and marketing human medicines. It engages in developing a pipeline of clinical candidates in the areas of gastrointestinal diseases, … WebIronwood Pharmaceuticals Ironwood is dedicated to advancing the treatment of GI diseases and redefining the standard of care for millions of GI patients. Industry Biotechnology Location Boston, MA Size 201 - 500 employees Perks and Benefits Health & Wellness and more Working at Ironwood Pharmaceuticals
Ironwood pharmaceuticals ma
Did you know?
WebApr 14, 2024 · Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Rating) was the recipient of unusually large options trading activity on Thursday. Stock traders acquired 4,553 call options on the stock. This ... WebPharmaceutical Manufacturing Company size 201-500 employees Headquarters Boston, MA Type Public Company Founded 1998 Locations Primary 100 Summer Street Boston, MA …
WebApr 10, 2024 · Ironwood Pharmaceuticals' mailing address is 100 SUMMER STREET SUITE 2300, BOSTON MA, 02110. The official website for the company is www.ironwoodpharma.com . The biotechnology company can be reached via phone at (617) 621-7722 , via email at [email protected] , or via fax at 617-494-0480 . WebMay 17, 2024 · Ironwood Pharmaceuticals (Nasdaq:IRWD) is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.
WebIronwood Pharmaceuticals Profile and History . Ironwood Pharmaceuticals, headquartered in Boston, Massachusetts, and established in 1998, is a specialty and generic drug manufacturing company specializing in gastrointestinal pharmaceutical solutions. WebRevenue. $100M to $500M (USD) Industry. Healthcare. Headquarters. Cambridge, Massachusetts. Ironwood Pharmaceuticals website. Ironwood Pharmaceuticals, Inc is a …
WebApr 14, 2024 · Ironwood Pharmaceuticals stock opened at $11.10 on Friday. The company has a 50-day simple moving average of $10.97 and a 200-day simple moving average of $11.23. The firm has a market ...
WebMar 31, 2024 · Ironwood Pharmaceuticals, Inc. - Corporate Governance - Board of Directors Board of Directors Andrew Dreyfus President and Chief Executive Officer for Blue Cross Blue Shield of Massachusetts Andrew Dreyfus joined our board of directors in April 2016. Mr. increase in owners capitalWebIronwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI … Mr. Emany has served as our chief financial officer since December 2024. Prior to … The Boston Globe named Ironwood Pharmaceuticals a Top Place to Work for … Our in-market product, LINZESS® (linaclotide), discovered in-house, is the … Ironwood Pharmaceuticals wants to make our careers website accessible to all … In November 2024 into a collaboration and license option agreement with COUR … Ironwood Pharmaceuticals. 100 Summer Street Suite 2300 Boston MA 02110. … Ironwood Pharmaceuticals is a patient-focused, biopharmaceutical company on … By providing your email address below, you are providing consent to Ironwood … One in five Americans suffer from GI diseases, resulting in millions of hospital … increase in orderincrease in oxygen deliveryWebLINZESS® (linaclotide) is a prescription medication used in adults to treat irritable bowel syndrome with constipation (IBS‑C) and chronic idiopathic constipation (CIC). "Idiopathic" means the cause of the constipation is unknown. It is not known if LINZESS is safe and effective in children less than 18 years of age. IMPORTANT RISK INFORMATION increase in overdose deathsWebApr 12, 2024 · Shares of IRWD opened at $10.77 on Wednesday. Ironwood Pharmaceuticals, Inc. has a 1 year low of $9.73 and a 1 year high of $12.66. The company has a market cap of $1.66 billion, a price-to ... increase in operating income formulaWebRevenue. $100M to $500M (USD) Industry. Healthcare. Headquarters. Cambridge, Massachusetts. Ironwood Pharmaceuticals website. Ironwood Pharmaceuticals, Inc is a drug manufacturer that develops and markets medicines of different types. One of its main products, Linaclotide, is drug approved by the U.S. Food and Drug Administration (FDA) … increase in owner\u0027s equity is calledWebAddress: 100 Summer St Ste 2300 Boston, MA, 02110-2156 United States See other locations Phone: Website: www.ironwoodpharma.com Employees (this site): Modelled Employees (all sites): Actual Revenue: $410.60 million Actual Sales Growth: -0.76% Net Income Growth: -66.87% Assets: $1,100 Fiscal Year End: DEC Year Started: Incorporated: increase in opioid overdoses in 2020